Mounjaro: A Breakthrough in Obesity Treatment
Introduction to Mounjaro Mounjaro, a medication developed by Eli Lilly, has emerged as a significant advancement in the fight against obesity. Approved by the FDA in 2022, Mounjaro, or tirzepatide, is designed for adults struggling with excess weight and associated health conditions. With obesity rates escalating globally, this medication’s introduction could not come at a…